Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3074% below fair value
$0.28−0.00 (-0.94%)
Close on Nov 12, 2026Market cap $38.62MP/E –Yield –
Xtant Medical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Xtant Medical's total debt was $11.01M at Jun 30, 2026. For fiscal 2025 it was $14.53M, down 34.1% from the year before. Over ten years it grew -10.5% a year on average. The highest annual figure on record is $77.94M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.53M | -34.1% |
| FY2024 | Dec 31, 2024 | $22.04M | +28.4% |
| FY2023 | Dec 31, 2023 | $17.17M | +42.8% |
| FY2022 | Dec 31, 2022 | $12.02M | +2.0% |
| FY2021 | Dec 31, 2021 | $11.79M | -29.8% |
| FY2020 | Dec 31, 2020 | $16.80M | -78.0% |
| FY2019 | Dec 31, 2019 | $76.24M | -2.2% |
| FY2018 | Dec 31, 2018 | $77.94M | +16.1% |
| FY2017 | Dec 31, 2017 | $67.11M | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $44.23M | +111.4% |
| FY2014 | Dec 31, 2014 | $20.92M | +27.3% |
| FY2013 | Dec 31, 2013 | $16.43M | +13.1% |
| FY2012 | Dec 31, 2012 | $14.53M | +75.6% |
| FY2011 | Dec 31, 2011 | $8.27M | +241.2% |
| FY2010 | Dec 31, 2010 | $2.42M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.01M | -50.6% |
| Q1 FY2026 | Mar 31, 2026 | $11.82M | -46.7% |
| Q4 FY2025 | Dec 31, 2025 | $14.53M | -34.1% |
| Q3 FY2025 | Sep 30, 2025 | $17.40M | -20.5% |
| Q2 FY2025 | Jun 30, 2025 | $22.28M | +2.3% |
| Q1 FY2025 | Mar 31, 2025 | $22.17M | +31.7% |
| Q4 FY2024 | Dec 31, 2024 | $22.04M | +28.4% |
| Q3 FY2024 | Sep 30, 2024 | $21.89M | +27.4% |
| Q2 FY2024 | Jun 30, 2024 | $21.77M | +27.2% |
| Q1 FY2024 | Mar 31, 2024 | $16.83M | -1.3% |
| Q4 FY2023 | Dec 31, 2023 | $17.17M | +42.8% |
| Q3 FY2023 | Sep 30, 2023 | $17.19M | +43.7% |
| Q2 FY2023 | Jun 30, 2023 | $17.11M | +43.7% |
| Q1 FY2023 | Mar 31, 2023 | $17.04M | +43.9% |
| Q4 FY2022 | Dec 31, 2022 | $12.02M | +2.0% |
| Q3 FY2022 | Sep 30, 2022 | $11.96M | +2.4% |
| Q2 FY2022 | Jun 30, 2022 | $11.90M | +1.9% |
| Q1 FY2022 | Mar 31, 2022 | $11.84M | -28.2% |
| Q4 FY2021 | Dec 31, 2021 | $11.79M | -29.8% |
| Q3 FY2021 | Sep 30, 2021 | $11.68M | -85.3% |
| Q2 FY2021 | Jun 30, 2021 | $11.68M | -84.9% |
| Q1 FY2021 | Mar 31, 2021 | $16.49M | -78.7% |
| Q4 FY2020 | Dec 31, 2020 | $16.80M | -78.0% |
| Q3 FY2020 | Sep 30, 2020 | $79.63M | +6.2% |
| Q2 FY2020 | Jun 30, 2020 | $77.53M | +5.0% |
| Q1 FY2020 | Mar 31, 2020 | $77.35M | +6.5% |
| Q4 FY2019 | Dec 31, 2019 | $76.24M | -2.2% |
| Q3 FY2019 | Sep 30, 2019 | $74.99M | -1.3% |
| Q2 FY2019 | Jun 30, 2019 | $73.83M | -7.0% |
| Q1 FY2019 | Mar 31, 2019 | $72.66M | +8.3% |
| Q4 FY2018 | Dec 31, 2018 | $77.94M | +18.8% |
| Q3 FY2018 | Sep 30, 2018 | $75.94M | – |
| Q2 FY2018 | Jun 30, 2018 | $79.43M | +60.5% |
| Q4 FY2017 | Dec 31, 2017 | $67.11M | – |
| Q3 FY2017 | Sep 30, 2017 | $65.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $49.49M | – |
See a number that looks wrong?